| CAS ID: | 143831-71-4 |
| Molecular Formula: | |
| Molecular Weight: | g/mol |
| Monoisotopic Mass: | g/mol |
| Class: | Protein based biotech |
| Natural Product: | No |
| Other Names: | HUMAN DNASE-1 | PULMOZYME | DORNASE ALFA | DORNASE ALFA (DESOXYRIBONUCLEASE) |
| Analysis: | N/A |
Trial Record 1
| ClinicalTrial ID | NCT00117208 | Disease | Cystic fibrosis |
| Phase | Phase 2 | Status | Completed |
| First Received | July 4, 2005 | Last Verified | February 2, 2010 |
| Sponsor | Pharmaxis | ||
Trial Record 2
| ClinicalTrial ID | NCT00557089 | Disease | Cystic fibrosis |
| Phase | Phase 4 | Status | Completed |
| First Received | November 12, 2007 | Last Verified | September 2, 2013 |
| Sponsor | The Hospital for Sick Children | ||
Trial Record 3
| ClinicalTrial ID | NCT00179998 | Disease | Cystic fibrosis |
| Phase | Phase 2 | Status | Unknown |
| First Received | September 16, 2005 | Last Verified | August 20, 2013 |
| Sponsor | Nationwide Children's Hospital | ||
Trial Record 4
| ClinicalTrial ID | NCT00680316 | Disease | Cystic fibrosis |
| Phase | Phase 4 | Status | Terminated |
| First Received | May 20, 2008 | Last Verified | January 12, 2017 |
| Sponsor | Genentech, Inc. | ||
Trial Record 5
| ClinicalTrial ID | NCT01712334 | Disease | Cystic fibrosis |
| Phase | Phase 4 | Status | Completed |
| First Received | October 23, 2012 | Last Verified | May 1, 2014 |
| Sponsor | Genentech, Inc. | ||
Trial Record 6
| ClinicalTrial ID | NCT00434278 | Disease | Cystic fibrosis |
| Phase | Phase 4 | Status | Terminated |
| First Received | February 13, 2007 | Last Verified | May 16, 2017 |
| Sponsor | Genentech, Inc. | ||
Trial Record 7
| ClinicalTrial ID | NCT00534079 | Disease | Cystic fibrosis |
| Phase | Phase 3 | Status | Completed |
| First Received | September 24, 2007 | Last Verified | December 4, 2014 |
| Sponsor | University of Jena | ||
Trial Record 8
| ClinicalTrial ID | NCT01155752 | Disease | Cystic fibrosis |
| Phase | Phase 3 | Status | Withdrawn |
| First Received | July 2, 2010 | Last Verified | July 21, 2017 |
| Sponsor | Milton S. Hershey Medical Center | ||
Trial Record 9
| ClinicalTrial ID | NCT00416182 | Disease | Cystic fibrosis |
| Phase | Phase 2 | Status | Completed |
| First Received | December 27, 2006 | Last Verified | November 14, 2014 |
| Sponsor | University of Vermont | ||
Trial Record 10
| ClinicalTrial ID | NCT00265434 | Disease | Cystic fibrosis |
| Phase | Phase 3 | Status | Completed |
| First Received | December 14, 2005 | Last Verified | December 4, 2014 |
| Sponsor | University of Jena | ||
| PubChem: | 17397980 |
| ChEMBL: | CHEMBL1201431 |